{"id":"https://openalex.org/W2889748005","doi":"https://doi.org/10.1200/jco.2017.35.15_suppl.e14575","title":"Toxicities associated with checkpoint inhibitor immunotherapy: The Karmanos Cancer Center experience.","display_name":"Toxicities associated with checkpoint inhibitor immunotherapy: The Karmanos Cancer Center experience.","publication_year":2017,"publication_date":"2017-05-20","ids":{"openalex":"https://openalex.org/W2889748005","doi":"https://doi.org/10.1200/jco.2017.35.15_suppl.e14575","mag":"2889748005"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2017.35.15_suppl.e14575","doi":"https://doi.org/10.1200/jco.2017.35.15_suppl.e14575","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2017.35.15_suppl.e14575","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060083195","display_name":"Misako Nagasaka","orcid":"https://orcid.org/0000-0001-5308-615X","observed_orcids":["https://orcid.org/0000-0001-5308-615X"]},"institutions":[{"id":"https://openalex.org/I185443292","display_name":"Wayne State University","ror":"https://ror.org/01070mq45","country_code":"US","type":"education","lineage":["https://openalex.org/I185443292"]},{"id":"https://openalex.org/I4210090317","display_name":"The Barbara Ann Karmanos Cancer Institute","ror":"https://ror.org/00ee40h97","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800590384","https://openalex.org/I4210090317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Misako Nagasaka","raw_affiliation_strings":["Department of Oncology, Karmanos Cancer Institute/Wayne State University, Detroit, MI;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Karmanos Cancer Institute/Wayne State University, Detroit, MI;","institution_ids":["https://openalex.org/I185443292","https://openalex.org/I4210090317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022959103","display_name":"Ramia Alhasan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I185443292","display_name":"Wayne State University","ror":"https://ror.org/01070mq45","country_code":"US","type":"education","lineage":["https://openalex.org/I185443292"]},{"id":"https://openalex.org/I2800326109","display_name":"Detroit Medical Center","ror":"https://ror.org/05gehxw18","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800326109"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Roba S Alhasan","raw_affiliation_strings":["Department of Internal Medicine, Wayne State University, Detroit Medical Center, Detroit, MI;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Wayne State University, Detroit Medical Center, Detroit, MI;","institution_ids":["https://openalex.org/I185443292","https://openalex.org/I2800326109"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067874001","display_name":"Marcus A. Crosby","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I185443292","display_name":"Wayne State University","ror":"https://ror.org/01070mq45","country_code":"US","type":"education","lineage":["https://openalex.org/I185443292"]},{"id":"https://openalex.org/I4210090317","display_name":"The Barbara Ann Karmanos Cancer Institute","ror":"https://ror.org/00ee40h97","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800590384","https://openalex.org/I4210090317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marcus Crosby","raw_affiliation_strings":["Department of Radiation Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiation Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI;","institution_ids":["https://openalex.org/I185443292","https://openalex.org/I4210090317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001774522","display_name":"Nithin Thummala","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I185443292","display_name":"Wayne State University","ror":"https://ror.org/01070mq45","country_code":"US","type":"education","lineage":["https://openalex.org/I185443292"]},{"id":"https://openalex.org/I4210090317","display_name":"The Barbara Ann Karmanos Cancer Institute","ror":"https://ror.org/00ee40h97","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800590384","https://openalex.org/I4210090317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nithin Thummala","raw_affiliation_strings":["Department of Radiology, Karmanos Cancer Institute, Wayne State University, Detroit, MI;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiology, Karmanos Cancer Institute, Wayne State University, Detroit, MI;","institution_ids":["https://openalex.org/I185443292","https://openalex.org/I4210090317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100649758","display_name":"Seongho Kim","orcid":"https://orcid.org/0000-0003-1120-073X","observed_orcids":["https://orcid.org/0000-0003-1120-073X","https://orcid.org/0000-0002-9575-8847"]},"institutions":[{"id":"https://openalex.org/I185443292","display_name":"Wayne State University","ror":"https://ror.org/01070mq45","country_code":"US","type":"education","lineage":["https://openalex.org/I185443292"]},{"id":"https://openalex.org/I4210090317","display_name":"The Barbara Ann Karmanos Cancer Institute","ror":"https://ror.org/00ee40h97","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800590384","https://openalex.org/I4210090317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Seongho Kim","raw_affiliation_strings":["Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, MI;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, MI;","institution_ids":["https://openalex.org/I185443292","https://openalex.org/I4210090317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016774003","display_name":"Judith Abrams","orcid":"https://orcid.org/0000-0001-9171-6458","observed_orcids":["https://orcid.org/0000-0001-9171-6458"]},"institutions":[{"id":"https://openalex.org/I185443292","display_name":"Wayne State University","ror":"https://ror.org/01070mq45","country_code":"US","type":"education","lineage":["https://openalex.org/I185443292"]},{"id":"https://openalex.org/I4210090317","display_name":"The Barbara Ann Karmanos Cancer Institute","ror":"https://ror.org/00ee40h97","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800590384","https://openalex.org/I4210090317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Judith Abrams","raw_affiliation_strings":["Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, MI;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, MI;","institution_ids":["https://openalex.org/I185443292","https://openalex.org/I4210090317"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5008487747","display_name":"Ammar W. Sukari","orcid":"https://orcid.org/0000-0003-1968-0459","observed_orcids":["https://orcid.org/0000-0003-1968-0459"]},"institutions":[{"id":"https://openalex.org/I185443292","display_name":"Wayne State University","ror":"https://ror.org/01070mq45","country_code":"US","type":"education","lineage":["https://openalex.org/I185443292"]},{"id":"https://openalex.org/I4210090317","display_name":"The Barbara Ann Karmanos Cancer Institute","ror":"https://ror.org/00ee40h97","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800590384","https://openalex.org/I4210090317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ammar Sukari","raw_affiliation_strings":["Department of Oncology, Karmanos Cancer Institute/Wayne State University, Detriot, MI;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Karmanos Cancer Institute/Wayne State University, Detriot, MI;","institution_ids":["https://openalex.org/I185443292","https://openalex.org/I4210090317"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"35","issue":"15_suppl","first_page":"e14575","last_page":"e14575"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pd-1-inhibitors","display_name":"PD-1 inhibitors","score":0.8560000061988831},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitor-toxicity","display_name":"immune checkpoint inhibitor toxicity","score":0.8809999823570251},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.9020000100135803},{"id":"https://openalex.org/keywords/pneumonitis","display_name":"pneumonitis","score":0.9660000205039978},{"id":"https://openalex.org/keywords/fatigue","display_name":"fatigue","score":0.7149999737739563},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.6489999890327454},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":1.0},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.7400000095367432},{"id":"https://openalex.org/keywords/renal-cell-carcinoma","display_name":"renal cell carcinoma","score":0.875},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.7699999809265137},{"id":"https://openalex.org/keywords/hodgkin-lymphoma","display_name":"Hodgkin's disease","score":0.8029999732971191},{"id":"https://openalex.org/keywords/head-and-neck-squamous-cell-carcinoma","display_name":"head and neck squamous cell carcinoma","score":0.9580000042915344},{"id":"https://openalex.org/keywords/small-cell-lung-cancer","display_name":"small cell lung cancer","score":0.902999997138977},{"id":"https://openalex.org/keywords/anemia","display_name":"anemia","score":0.4440000057220459},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.9200000166893005},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.8899999856948853},{"id":"https://openalex.org/keywords/acute-kidney-injury","display_name":"acute kidney injury","score":0.7329999804496765},{"id":"https://openalex.org/keywords/hypothyroidism","display_name":"hypothyroidism","score":0.8870000243186951},{"id":"https://openalex.org/keywords/elevated-liver-enzymes","display_name":"elevated liver enzymes","score":0.9100000262260437},{"id":"https://openalex.org/keywords/colitis","display_name":"colitis","score":0.9620000123977661}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9362850189208984},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7041386365890503},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.587946355342865},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.5650821924209595},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.550647497177124},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.5329640507698059},{"id":"https://openalex.org/C2781068499","wikidata":"https://www.wikidata.org/wiki/Q3242950","display_name":"Kidney cancer","level":3,"score":0.4931177794933319},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.49150097370147705},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4814545512199402},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.4706767201423645},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.4529995322227478},{"id":"https://openalex.org/C2776833033","wikidata":"https://www.wikidata.org/wiki/Q1783924","display_name":"Head and neck squamous-cell carcinoma","level":4,"score":0.4476555287837982},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.33680784702301025},{"id":"https://openalex.org/C2776530083","wikidata":"https://www.wikidata.org/wiki/Q1783924","display_name":"Head and neck cancer","level":3,"score":0.32403212785720825},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2156556248664856},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.21500447392463684}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2017.35.15_suppl.e14575","doi":"https://doi.org/10.1200/jco.2017.35.15_suppl.e14575","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2017.35.15_suppl.e14575","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2914267414","https://openalex.org/W4367835168","https://openalex.org/W4223481109","https://openalex.org/W2996162850","https://openalex.org/W2791513392","https://openalex.org/W3210743403","https://openalex.org/W4214628103","https://openalex.org/W2591602708","https://openalex.org/W2952834266","https://openalex.org/W3093864593"],"abstract_inverted_index":{"e14575":[0],"Background:":[1],"PD-1":[2,53,97,160],"inhibitors":[3,54,98,161],"work":[4],"by":[5,113],"re-instating":[6],"the":[7,243,292],"natural":[8],"anti-cancer":[9],"immune-mediated":[10],"cytotoxicity.":[11],"Although":[12],"this":[13],"new":[14],"class":[15],"of":[16,52,67,106,108,159,296],"therapy":[17],"offers":[18],"hope":[19],"for":[20,117,123],"many":[21],"advanced":[22],"stage":[23],"cancer":[24,192,226],"patients":[25],"(pts),":[26],"data":[27,164],"on":[28,85,99,180,269,328],"pts":[29,45,153,278],"who":[30,46,95],"are":[31,39],"more":[32,264,287,327],"likely":[33],"to":[34,134,163,259,282],"experience":[35,260,283],"adverse":[36],"events":[37],"(AE)":[38],"not":[40,268],"available.":[41],"Methods:":[42],"Data":[43],"from":[44,61],"received":[47,96,154,247],"at":[48,155],"least":[49,156],"one":[50,157],"dose":[51,158],"before":[55],"August":[56],"31,":[57],"2016,":[58],"were":[59,80,90,132,186,228],"captured":[60],"our":[62,322],"institution\u2019s":[63],"pharmacy":[64],"database.":[65],"AE":[66],"anemia,":[68],"neutropenia,":[69],"thrombocytopenia,":[70],"acute":[71],"kidney":[72],"injury,":[73],"hypothyroidism,":[74],"transaminitis,":[75],"pneumonitis,":[76],"colitis":[77],"and":[78,82,120,127,142,148,176,200,215,242,313],"fatigue":[79,288,332],"recorded":[81],"graded":[83],"based":[84],"CTCAEv4.":[86],"Baseline":[87],"pt":[88],"characteristics":[89],"statistically":[91],"compared":[92],"between":[93,137],"subjects":[94],"a":[100,253,270],"clinical":[101,254,329],"trial":[102,149,172,181,255,271,277],"vs":[103,311],"as":[104,294],"part":[105],"standard":[107,295],"care":[109,297],"(on":[110],"vs.":[111,140],"off-study)":[112],"Fisher\u2019s":[114],"exact":[115],"test":[116,122],"categorical":[118],"variables":[119],"Kruskal-Wallis":[121],"continuous":[124],"variables.":[125],"Univariable":[126],"multivariable":[128],"logistic":[129],"regression":[130],"models":[131],"fit":[133],"assess":[135],"associations":[136],"toxicities":[138],"(Grade0-1":[139],"Grade2+)":[141],"predictors":[143],"(age,":[144],"agent,":[145],"primary":[146,314],"tumor,":[147],"status).":[150],"Results:":[151],"231":[152],"prior":[162],"cut-off.":[165],"Median":[166],"age":[167],"was":[168,325,333],"65":[169],"(24-92)":[170],"off":[171],"(n":[173,182],"=":[174,183,274,300,318],"125)":[175],"59.":[177],"5":[178],"(25-79)":[179],"106).":[184],"There":[185],"117":[187],"(51%)":[188],"non-small":[189],"cell":[190,197,218,224],"lung":[191,225],"(NSCLC),":[193],"41":[194],"(18%)":[195],"renal":[196],"carcinoma":[198,219],"(RCC)":[199],"73":[201],"(32%)":[202],"others.":[203,231],"24":[204],"(10%)":[205],"melanoma,":[206],"18":[207],"(8%)":[208],"Hodgkin\u2019s":[209],"lymphoma":[210],"(HL),":[211],"9":[212],"(4%)":[213,222],"head":[214],"neck":[216],"squamous":[217],"(HNSCC),":[220],"8":[221],"small":[223],"(SCLC)":[227],"included":[229],"in":[230,252],"129":[232],"(56%)":[233],"had":[234,239,256,279],"nivolumab":[235],"alone,":[236],"50":[237],"(22%)":[238],"pembrolizumab":[240],"alone":[241],"rest":[244],"52":[245],"(23%)":[246],"combination":[248],"treatment.":[249],"Pts":[250],"participating":[251],"higher":[257],"odds":[258,281],"grade":[261,284],"2":[262,285],"or":[263,286],"pneumonitis":[265,324],"than":[266,289],"those":[267,290],"(unadjusted":[272,298],"p":[273,299,317],"0.038).":[275],"On":[276],"lower":[280],"receiving":[291],"agent":[293,308,310],"0.026)":[301],"which":[302],"remained":[303],"significant":[304],"after":[305],"adjusting":[306],"age,":[307],"(single":[309],"combination)":[312],"tumor":[315],"(adjusted":[316],"0.004).":[319],"Conclusions:":[320],"In":[321],"observation,":[323],"seen":[326,334],"trials":[330],"whereas":[331],"less.":[335]},"counts_by_year":[{"year":2018,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2018-09-27T00:00:00"}